Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489]. - Curtis, Sean P.; Bockow, Barry; Fisher, Chester; Olaleye, Joseph; Compton, Amy; Ko, Amy T.; Reicin, Alise S. (BMC Musculoskeletal Disorders, 2005)